Leuprorelin
Leuprorelin is used for the treatment of hormone-based tumour which includes prostate cancer, breast cancer, lymphoma, certain kinds of leukaemia, uterine fibroids, and endometriosis. This medicine is a synthetic version of a hormone called gonadotropin-releasing hormone (GnRH).
Apart from these, it is also used to treat the early onset of puberty. It is administered through an injection into a muscle or under the skin by a healthcare professional only. Prolonged usage leads to a substantial decline of testosterone in males and a decrease in estradiol in females.
It is also used to avoid premature ovulation in in-vitro fertilization processes. In some cases, this medication may be harmful if inhaled, can cause allergic skin reactions, asthma-like symptoms and breathing difficulties.
This drug is also used to delay puberty in transgender boys and girls until they are old enough to start hormone-replacement therapy. It has also been used on an experimental basis to reduce sexual urges in paedophiles and other kinds of paraphilias.
This medication is helpful in treating the below provided problems:
-
Hypersensitivity
-
Vaginal Bleeding
A patient can suffer from the following side effects:
-
Decreased Libido
-
Testicular Atrophy
-
Increased Sweating
-
Erectile Dysfunction
-
Bone Pain
-
Hot Flashes
-
Injection Site Reaction
-
Is It safe with alcohol?
Interaction with alcohol is unknown. Please consult your doctor. -
Are there any pregnancy warnings?
This medication is highly unsafe to use during pregnancy.
Human and animal studies have shown significant adverse effects on the foetus. Please consult your doctor. -
Are there any breast-feeding warnings?
Unknown. Human and animal studies are not available. Please consult your doctor. -
Is it safe to drive while on this medicine?
This medication is not safe while driving. -
Does this affect kidney function?
There is no data available. Please consult a doctor before consuming the drug. -
Does this affect liver function?
There is no data available. Please consult a doctor before consuming the drug. -
What is the onset of action?
The effect of this medicine is shown after 60 - 90 minutes of administration. -
How long is the duration of effect?
The duration of action of medicine vary form person to person. This medicine shows a effect for about 7 to 10 days.
-
Are there any missed dose instructions?
If you miss a dose of this medication, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose. -
Are there any overdose instructions?
Seek emergency medical treatment or contact the doctor in case of an overdose.
Below is the list of medicines, which contains Leuprorelin as ingredient
- Zydus Cadila
- Samarth Life Sciences Pvt Ltd
- Celon Laboratories Ltd
- Intas Pharmaceuticals Ltd
- Life Medicare & Biotech Pvt Ltd
- Samarth Life Sciences Pvt Ltd
- Sun Pharmaceutical Industries Ltd
- Bharat Serums & Vaccines Ltd
- Abbott India Ltd
- Bharat Serums & Vaccines Ltd
This medicine belongs to the class of GnRH i.e. gonadotropin hormone receptor agonist. Its administration results in inhibiting the secretion of follicle stimulating and luteinizing hormones (FSH & LH), which leads to decrease the testosterone and estrogen level in blood.
Whenever you take more than one medicine, or mix it with certain foods or beverages, you"re at risk of a drug interaction.
-
Interaction with Medicine
Ques: What is Leuprorelin?
Ques: How long do I need to use Leuprorelin before I see improvement in my condition?
Ques: At what frequency do I need to use Leuprorelin?
Ques: Should I use Leuprorelin empty stomach, before food or after food?
Ques: What are the instructions for the storage and disposal of Leuprorelin?
-
Leuprorelin- Drug Information Portal [Internet]. druginfo.nlm.nih.gov. 2019 [Cited 4 December 2019]. Available from:
https://druginfo.nlm.nih.gov/drugportal/name/leuprorelin -
Leuprolide- DrugBank [Internet]. Drugbank.ca. 2017 [Cited 4 December 2019]. Available from:
https://www.drugbank.ca/drugs/DB00007 -
Prostap 3 DCS 11.25 mg Powder and Solvent for Prolonged-release Suspension for Injection in Pre-filled syringe- EMC [Internet] medicines.org.uk. 2019 [Cited 4 December 2019]. Available from:
https://www.medicines.org.uk/emc/product/4651/smpc
Lybrate is a medium to provide our audience with the common information on medicines and does not guarantee its accuracy or exhaustiveness. Even if there is no mention of a warning for any drug or combination, it never means that we are claiming that the drug or combination is safe for consumption without any proper consultation with an expert.
Lybrate does not take responsibility for any aspect of medicines or treatments. If you have any doubts about your medication, we strongly recommend you to see a doctor immediately.